Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2017

Sep 5, 2017

35086_dirs_2017-09-05_8c7c1f64-3b0c-44dc-b215-f6f28f5d11b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-09-01

Reporting Person: Saoud Jay (SVP and Head of R&D)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-01 Employee Stock Option (Right to Buy) $6.45 A 100000 Acquired 2017-08-31 Common Stock (100000) Direct

Footnotes

F1: This option vested as to 25% of the shares on September 1, 2018 and then in quarterly installments over 3 years thereafter.